New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes...
New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci
About this item
Full title
Author / Creator
Publisher
Kidlington: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Kidlington: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
Highlights► A new recombinant 30-valent M protein-based group A streptococcal vaccine. ► Vaccine design based on current epidemiology of pharyngeal and invasive infections. ► Bactericidal antibodies evoked against all vaccine serotypes of streptococci. ► Vaccine antisera were bactericidal against a number of non-vaccine serotypes.
Alternative Titles
Full title
New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3195966
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3195966
Other Identifiers
ISSN
0264-410X
E-ISSN
1873-2518
DOI
10.1016/j.vaccine.2011.09.005
